But now, the FDA has just approved one that helps patients with anemia – a devastating side effect of myelofibrosis. Andrew and Esther Schorr are on a mission – spreading the word about ...

Aplastic anemia is a rare but life-threatening condition of blood disorder that occurs when your bone marrow cannot make enough new blood cells for your body to function normally. It can develop ...

In addition to CK0804, Cellenkos' CK0801 candidate for aplastic anemia has shown promising efficacy, including transfusion independence in treated patients. Myelofibrosis is a rare, chronic, and ...